Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A
5 clinical trials · Condition
◉ Watch Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A
| Record | Firm | Date |
|---|---|---|
| Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT01664897) | M.D. Anderson Cancer Center | 2013-05-16 |
| Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia (NCT01307579) | Children's Oncology Group | 2011-04-04 |
| Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers (NCT01254578) | National Cancer Institute (NCI) | 2010-11-24 |
| Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia (NCT00416598) | National Cancer Institute (NCI) | 2006-11-15 |
| Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission (NCT00093470) | National Cancer Institute (NCI) | 2004-08-18 |
Track Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A automatically
Every clearance here is in the API, with alerts when new ones post.